Listed

Advanced Drainage Systems, Inc.: Form 10-Q for the period ended Dec 31, 2020

Filed with the SEC on Feb 4, 2021 and accepted by EDGAR at Feb 4, 2021, 16:01 ET.

Share

Management's discussion and analysis

As filed, 57,165 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Unless the context otherwise indicates or requires, as used in this Quarterly Report on Form 10-Q, the terms “we,” “our,” “us,” “ADS” and the “Company” refer to Advanced Drainage Systems, Inc. and its directly- and indirectly-owned subsidiaries as a combined entity, except where it is clear that the terms mean only Advanced Drainage Systems, Inc. exclusive of its subsidiaries.

Our fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, references to “year” pertain to our fiscal year. For example, 2021 refers to fiscal 2021, which is the period from April 1, 2020 to March 31, 2021.

The following discussion and analysis of the financial condition and results of our operations should be read in conjunction with our Condensed Consolidated Financial Statements and related footnotes included elsewhere in this Quarterly Report on Form 10-Q and with the audited Consolidated Financial Statements included in our Fiscal 2020 Form 10-K, as filed with the Securities and Exchange Commission (the “SEC”) on June 1, 2020. In addition to historical condensed consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. This discussion contains forward-looking statements that are based on the beliefs of our management, as well as assumptions made by, and information currently available to, our management. Our actual results could differ materially from those discussed in the forward-looking statements. For more information, see the section below entitled “Forward Looking Statements.”

We consolidate our joint ventures for purposes of GAAP, except for our South American Joint Venture.

Overview

We are the leading global manufacturer of water management products and solutions for non-residential, residential, infrastructure and agricultural applications. With the acquisition of Infiltrator Water Technologies in the second quarter of fiscal 2020, we are now a leading provider of plastic leach field chambers, septic tanks and accessories, for use primarily in residential applications.

Impact of COVID-19

In March 2020, the World Health Organization categorized the novel coronavirus (“COVID-19”) as a pandemic, and it continues to spread throughout the United States and globally. The COVID-19 pandemic has resulted, and is likely to continue to result, in significant economic disruptions and may have an adverse effect on our business. Significant uncertainty exists concerning the magnitude of the impact and duration of the COVID-19 pandemic. While our production facilities are operating as essential businesses, the Company continues to assess the potential effects and may experience future impacts such as reduced operations or temporarily closing facilities.

Executive Summary

Third Quarter Fiscal 2021 Results

  • Net sales increased 23.6% to $486.1 million
  • Net income increased 128.4% to $54.0 million
  • Adjusted EBITDA, a non-GAAP measure, increased 52.1% to $138.9 million

Net sales increased $92.7 million, or 23.6%, to $486.1 million, as compared to $393.4 million in the prior year. Domestic pipe sales increased $46.3 million, or 22.3%, to $254.2 million. Domestic allied products & other sales increased $20.7 million, or 23.3%, to $109.6 million. Infiltrator Water Technologies sales increased $26.3 million, or 36.5%, to $98.4 million. These increases were driven by sales growth in both the U.S. construction and agriculture end markets.

Gross profit increased $45.1 million, or 36.6%, to $168.5 million as compared to $123.4 million in the prior year. The increase is primarily due an increase in sales volume of both pipe and allied products, favorable pricing and material cost and operational improvements offsetting inflationary costs.

Adjusted EBITDA, a non-GAAP measure, increased $47.5 million, or 52.1%, to $138.9 million, as compared to $91.3 million in the prior year. The increase is primarily due to the factors mentioned above. As a percentage of net sales, Adjusted EBITDA was 28.6% as compared to 23.2% in the prior year.

Year-to-Date Fiscal 2021 Results

  • Net sales increased 18.1% to $1.5 billion
  • Net income increased to $205.3 million, compared to a net loss of $195.3 million in the prior year
  • Adjusted EBITDA, a non-GAAP measure, increased 63.0% to $472.4 million
  • Cash provided by operating activities increased 51.5% to $448.8 million
  • Free cash flow, a non-GAAP measure, increased 56.4% to $391.1 million

Net sales increased $235.9 million, or 18.1%, to $1.539 billion, as compared to $1.303 billion in the prior year. Domestic pipe sales increased $68.5 million, or 9.1%, to $820.0 million. Domestic allied products & other sales increased $29.1 million, or 9.2%, to $344.5 million. These increases were driven by growth in both the U.S. construction and agriculture end markets. Infiltrator Water Technologies sales increased $169.6 million, or 123.8%, to $306.5 million, as compared to $137.0 million in the prior year.

Gross profit increased $355.1 million to $562.9 million as compared to $207.7 million in the prior year. The prior year gross profit includes $168.6 million of ESOP special dividend compensation expense. In addition, the year-to-date gross profit includes an incremental benefit from a full year of results from the Infiltrator Water Technologies business, as compared to five months of results in the prior year due to the timing of the acquisition. The remaining increase in gross profit is favorable material cost, increases in both pipe and allied product sales and an increase in operational efficiency.

Adjusted EBITDA, a non-GAAP measure, increased $182.6 million, or 63.0%, to $472.4 million, as compared to $289.8 million in the prior year. The increase is primarily due to the factors mentioned above. As a percentage of net sales, Adjusted EBITDA was 30.7% as compared to 22.2% in the prior year.

Results of Operations

Comparison of the Three Months ended December 31, 2020 to the Three Months ended December 30, 2019

The following table summarizes our operating results as a percentage of net sales that have been derived from our Condensed Consolidated Financial Statements for the periods presented. We believe this presentation is useful to investors in comparing historical results.

(In thousands)

(In thousands)

Consolidated Statements of Operations data: For the Three Months Ended December 31, 2020 2019
Net sales $486,145 100.0% $393,424 100.0%
Cost of goods sold 317,640 65.3 270,066 68.6
Gross profit 168,505 34.7 123,358 31.4
Selling expenses 30,537 6.3 29,967 7.6
General and administrative expenses 36,069 7.4 37,023 9.4
Loss on disposal of assets and costs from exit and disposal activities 980 0.2 1,755 0.4
Intangible amortization 17,956 3.7 13,593 3.5
Income (loss) from operations 82,963 17.1 41,020 10.4
Interest expense 8,433 1.7 13,191 3.4
Derivative (loss) gains and other (expense) income, net (165) — 39 —
Income (loss) before income taxes 74,695 15.4 27,790 7.1
Income tax expense 20,264 4.2 4,032 1.0
Equity in net loss (income) of unconsolidated affiliates 390 0.1 99 —
Net income (loss) 54,041 11.1 23,659 6.0
Less: net income attributable to noncontrolling interest 267 0.1 371 0.1
Net income (loss) attributable to ADS $53,774 11.1% $23,288 5.9%

Net sales - Net sales increased by $92.7 million, or 23.6%, for the three months ended December 31, 2020 compared to the three months ended December 31, 2019.

Three Months Ended December 31, 2020 Net Sales Intersegment Net Sales Net Sales from External Customers December 31, 2019 Net Sales Intersegment Net Sales Net Sales from External Customers
Pipe $254,209 $(1,311) $252,898 $207,897 $(342) $207,555
Infiltrator Water Technologies 98,409 (17,188) 81,221 72,083 (13,549) 58,534
International
International - Pipe 33,729 (2,970) 30,759 28,340 — 28,340
International - Allied Products & Other 11,648 — 11,648 10,114 — 10,114
Total International 45,377 (2,970) 42,407 38,454 — 38,454
Allied Products & Other 109,619 — 109,619 88,881 — 88,881
Intersegment Eliminations (21,469) 21,469 — (13,891) 13,891 —
Total Consolidated $486,145 $— $486,145 $393,424 $— $393,424
  • Pipe net sales to all customers for the three months ended December 31, 2020 increased by $46.3 million, or 22.3%, compared to the three months ended December 31, 2019. The increase was due to an increase in pipe volume resulting in a $40.6 million increase in sales and a $3.7 million increase as a result of price and product mix.
  • Infiltrator Water Technologies net sales to all customers increased $26.3 million for the three months ended December 31, 2020 compared to the three months ended December 31, 2019. The increase was primarily due to increased sales volume.
  • International net sales for the three months ended December 31, 2020 increased by $6.9 million, or 18.0%, compared to the three months ended December 31, 2019. The increase was primarily attributable to a $5.4 million increase in International Pipe Sales and a $1.5 million increase in International Allied Product sales.
  • Allied Products & Other net sales for the three months ended December 31, 2020 increased by $20.7 million, or 23.3%, compared to the three months ended December 31, 2019. The increase was due to price and product mix and an increase in sales volume.

Cost of goods sold and Gross profit - Cost of goods sold increased by $47.6 million, or 17.6%, and gross profit increased by $45.1 million, or 36.6%, in the three months ended December 31, 2020 over the comparable period in the previous year. Gross profit excluding Infiltrator Water Technologies, referred to as Legacy ADS gross profit, a Non-GAAP measure, increased 31.8%.

(In thousands)

Gross profit data: For the Three Months Ended December 31, 2020 2019 $ Variance % Variance
Pipe $58,679 $44,651 $14,028 31.4%
International 11,581 7,599 3,982 52.4
Allied Products & Other 53,913 41,983 11,930 28.4
Legacy ADS gross profit 124,173 94,233 29,940 31.8
Infiltrator Water Technologies 45,264 30,006 15,258 50.8
Intersegment eliminations (932) (881) (51) 5.8
Total gross profit $168,505 $123,358 $45,147 36.6%
  • Pipe gross profit increased primarily due to lower costs in material, labor and overhead. The increase was also attributable to the increase in volume sold discussed above.
  • Infiltrator Water Technologies gross profit increased due to the increased sales volume discussed above.
  • International gross profit increased primarily due to the increased sales discussed above and lower costs of materials.
  • Allied Products & Other gross profit increased primarily due to the increase in net sales discussed above and lower labor and overhead costs.

Operating expenses

Three Months Ended December 31, 2020 2019
Selling expenses 6.3% 7.6%
General and administrative expenses 7.4% 9.4%
Selling, general and administrative expenses 13.7% 17.0%

Selling expenses - As a percentage of net sales, selling expenses decreased to 6.3% in the three months ended December 31, 2020 compared to 7.6% in the three months ended December 31, 2019. The decrease as a percentage of net sales is the result of the Company’s cost mitigation steps.

General and administrative expenses - General and administrative expenses for the three months ended December 31, 2020 decreased $1.0 million from the prior year period. The decrease was primarily due to a $1.7 million decrease in transaction costs due to the Infiltrator Water Technologies acquisition.

Loss on disposal of assets and costs from exit and disposal activities - The decrease in Loss on disposal of assets and costs from exit and disposal activities is primarily due to asset disposals in fiscal 2020. See “Note 2. Loss on Disposal of Assets and Costs from Exit and Disposal Activities” for additional discussion.

Intangible amortization - Intangible amortization increased $4.4 million due to an increase in the Acquisition related identifiable intangible assets recorded in the fourth quarter of fiscal 2020 as we finalized the purchase price allocation.

Interest expense - Interest expense decreased $4.8 million in the three months ended December 31, 2020 compared to the same period in the previous fiscal year. The decrease was primarily due to decreased debt levels.

Derivative (loss) gain and other (expense) income, net - Derivative (loss) gains and other (expense) income decreased by $0.2 million for the three months ended December 31, 2020 compared to the same period in the previous fiscal year.

Income tax expense - The following table presents the effective tax rates for the three months ended December 31, 2020 and 2019.

Three Months Ended December 31, 2020 2019
Effective tax rate 27.1% 14.5%

The change in the effective tax rate was primarily due to a discrete income tax event related to the release of tax reserves. See “Note 13. Income Taxes” for additional information.

Equity in net loss (income) of unconsolidated affiliates - Equity in net loss (income) of unconsolidated affiliates represents our proportionate share of income or loss attributed to our unconsolidated joint venture in which we have significant influence, but not control, over operations. The Equity in net (income) loss of unconsolidated affiliates increased for the three months ended December 31, 2020 as compared to the same period in the previous fiscal year due to an increase in the current period loss at our South American Joint Venture.

Net income (loss) attributable to noncontrolling interest - Net income (loss) attributable to noncontrolling interest decreased for three months ended December 31, 2020 due to an increase in net income at our ADS Mexicana joint venture.

Comparison of the Nine Months ended December 31, 2020 to the Nine Months ended December 31, 2019

The following table summarizes our operating results as a percentage of net sales that have been derived from our Condensed Consolidated Financial Statements for the periods presented. We believe this presentation is useful to investors in comparing historical results.

(In thousands)

(In thousands)

Consolidated Statements of Operations data: For the Nine Months Ended December 31, 2020 2019
Net sales $1,538,971 100.0% $1,303,037 100.0%
Cost of goods sold 976,106 63.4 926,703 71.1
Cost of goods sold - ESOP special dividend compensation — — 168,610 12.9
Gross profit 562,865 36.6 207,724 15.9
Selling 89,283 5.8 86,303 6.6
General and administrative 104,800 6.8 116,486 8.9
Selling, general and administrative - ESOP special dividend compensation — — 78,142 6.0
Loss on disposal of assets and costs from exit and disposal activities 3,254 0.2 4,466 0.3
Intangible amortization 53,893 3.5 24,435 1.9
Income (loss) from operations 311,635 20.2 (102,108) (7.8)
Interest expense 27,763 1.8 70,787 5.4
Derivative (loss) gains and other (expense) income, net (883) (0.1) 118 —
Income (loss) before income taxes 284,755 18.5 (173,013) (13.3)
Income tax expense 79,291 5.2 22,855 1.8
Equity in net loss (income) of unconsolidated affiliates 150 — (538) —
Net income (loss) 205,314 13.3 (195,330) (15.0)
Less: net income attributable to noncontrolling interest 838 0.1 149 —
Net income (loss) attributable to ADS $204,476 13.3% $(195,479) (15.0)%

Net sales - Net sales increased by $235.9 million, or 18.1%, for the nine months ended December 31, 2020 compared to the nine months ended December 31, 2019.

Nine Months Ended December 31, 2020 Net Sales Intersegment Net Sales Net Sales from External Customers December 31, 2019 Net Sales Intersegment Net Sales Net Sales from External Customers
Pipe $819,994 $(4,793) $815,201 $751,483 $(684) $750,799
Infiltrator Water Technologies 306,548 (53,948) 252,600 136,972 (25,738) 111,234
International
International - Pipe 96,271 (3,866) 92,405 92,242 — 92,242
International - Allied Products & Other 34,233 — 34,233 33,330 — 33,330
Total International 130,504 (3,866) 126,638 125,572 — 125,572
Allied Products & Other 344,532 — 344,532 315,432 — 315,432
Intersegment Eliminations (62,607) 62,607 — (26,422) 26,422 —
Total Consolidated $1,538,971 $— $1,538,971 $1,303,037 $— $1,303,037
  • Pipe net sales to all customers for the nine months ended December 31, 2020 increased by $68.5 million, or 9.1%, compared to the nine months ended December 31, 2019. The increase was due to an increase in pipe volume resulting in a $68.3 million increase in sales partially offset by a $2.0 million decrease as a result of price and product mix.
  • Infiltrator Water Technologies net sales to all customers for the nine months ended December 31, 2020 increased by $169.6 million compared to the nine months ended December 31, 2019. The Company acquired Infiltrator Water Technologies on July 31, 2019 and therefore did not report any Infiltrator Water Technologies sales prior to August 2019.
  • International net sales for the nine months ended December 31, 2020 increased by $4.9 million, or 3.9%, compared to the nine months ended December 31, 2019. The increase was primarily attributable to a $4.0 million increase in International Pipe Sales and a $0.9 million increase in International Allied Product sales.
  • Allied Products & Other net sales for the nine months ended December 31, 2020 increased by $29.1 million, or 9.2%, compared to the nine months ended December 31, 2019. The increase was due to price and product mix and an increase in sales volume.

Cost of goods sold and Gross profit - Cost of goods sold increased by $49.4 million, or 5.3%, and gross profit increased by $355.1 million, or 171.0%, in the nine months ended December 31, 2020 over the comparable period in the previous year. The increase in gross profit was primarily due to the ESOP special dividend compensation expense from the special dividend in fiscal 2020 of $168.6 million allocated to Cost of goods sold. Gross profit excluding Infiltrator Water Technologies and Cost of goods sold – ESOP special dividend compensation, referred to as Legacy ADS gross profit, a Non-GAAP measure, increased 30.1%.

(In thousands)

Gross profit data: For the Nine Months Ended December 31, 2020 2019 $ Variance % Variance
Pipe $216,318 $146,212 $70,106 47.9%
International 34,948 24,562 10,386 42.3
Allied Products & Other 172,576 154,914 17,662 11.4
Legacy ADS gross profit 423,842 325,688 98,154 30.1
Infiltrator Water Technologies 139,941 52,505 87,436 166.5
Cost of goods sold - ESOP special dividend compensation — (168,610) 168,610 100.0
Intersegment eliminations (918) (1,859) 941 (50.6)
Total gross profit $562,865 $207,724 $355,141 171.0%
  • Pipe gross profit increased primarily due to lower costs in material, labor and overhead. The increase was also attributable to the increase in volume sold, offset by the decrease in the price and product mix of net sales discussed above.
  • The Company acquired Infiltrator Water Technologies on July 31, 2019 and therefore did not report any Infiltrator Water Technologies gross profit prior to August 2019.
  • International gross profit increased primarily due to lower cost of materials and the increased sales discussed above.
  • Allied Products & Other gross profit increased primarily due to the increase in net sales discussed above and lower labor and overhead costs.

Operating expenses

For the Nine Months Ended December 31, 2020 2019
Selling expenses 5.8% 6.6%
General and administrative expenses 6.8% 8.9%
Selling, general and administrative expenses 12.6% 15.6%

- 30 -

Selling expenses - As a percentage of net sales, selling expenses decreased to 5.8% in the nine months ended December 31, 2020 compared to 6.6% in the nine months ended December 31, 2019. The decrease as a percentage of net sales is the result of the Company’s cost mitigation steps.

General and administrative expenses - General and administrative expenses for the nine months ended December 31, 2020 decreased $11.7 million from the prior year period. The decrease was primarily due to a $21.2 million decrease in transaction costs. The decrease was offset by a $7.5 million increase in general and administrative expenses, including stock-based compensation, reported at Infiltrator Water Technologies.

Selling, general and administrative – ESOP special dividend compensation – In fiscal 2019, ESOP special dividend compensation expense of $78.1 million was allocated to selling, general and administrative expenses.

Loss on disposal of assets and costs from exit and disposal activities - The decrease in Loss on disposal of assets and costs from exit and disposal activities is primarily due to asset disposals in fiscal 2020. See “Note 2. Loss on Disposal of Assets and Costs from Exit and Disposal Activities” for additional discussion.

Intangible amortization - Intangible amortization increased primarily due to the addition of intangible assets related to the acquisition of Infiltrator Water Technologies.

Interest expense - Interest expense decreased $43.0 million in the nine months ended December 31, 2020 compared to the same period in the previous fiscal year. The decrease was primarily due to $33.2 million of the write-off of deferred financing costs and $4.2 million prepayment penalty related to the extinguishment of debt instruments in the nine months ended December 31, 2019. The remainder of the decrease is due to decreased debt levels.

Derivative (loss) gain and other (expense) income, net – Derivative (loss) gain and other (expense) income increased by $1.0 million for the nine months ended December 31, 2020 compared to the same period in the previous fiscal year.

Income tax expense – The following table presents the effective tax rates for the nine months ended December 31, 2020 and 2019.

For the Nine Months Ended December 31, 2020 2019
Effective tax rate 27.8% (13.2)%

The change in the effective tax rate was primarily due to a discrete income tax event related to stock appreciation from the additional ESOP shares allocated and the Acquisition. See “Note 13. Income Taxes” for additional information.

Equity in net (income) loss of unconsolidated affiliates - Equity in net (income) loss of unconsolidated affiliates represents our proportionate share of income or loss attributed to our unconsolidated joint venture in which we have significant influence, but not control, over operations. The Equity in net (income) loss of unconsolidated affiliates decreased for the nine months ended December 31, 2020 as compared to the same period in the previous fiscal year due to a decrease in the current period income at our South American Joint Venture.

Net income attributable to noncontrolling interest - Net income attributable to noncontrolling interest increased for the nine months ended December 31, 2020 due to an increase in net income at our ADS Mexicana joint venture.

Adjusted EBITDA and Adjusted EBITDA Margin - Adjusted EBITDA and Adjusted EBITDA Margin, which are non-GAAP financial measures, have been presented in this Quarterly Report on Form 10-Q as supplemental measures of financial performance that are not required by, or presented in accordance with GAAP and should not be considered as alternatives to net income as measures of financial performance or cash flows from operations or any other performance measure derived in accordance with GAAP. We calculate Adjusted EBITDA as net income (loss) before interest, income taxes, depreciation and amortization, stock-based compensation expense, non-cash charges and certain other expenses. We calculate Adjusted EBITDA Margin as Adjusted EBITDA divided by net sales.

Adjusted EBITDA and Adjusted EBITDA Margin are included in this Form 10-Q because they are key metrics used by management and our board of directors to assess our consolidated financial performance. These non-GAAP financial measures are frequently used by analysts, investors and other interested parties to evaluate companies in our industry. In addition to covenant compliance and executive performance evaluations, we use these non-GAAP financial measures to supplement GAAP measures of performance to evaluate the effectiveness of our consolidated business strategies, to make budgeting decisions and to compare our performance against that of other peer companies using similar measures. We use Adjusted EBITDA Margin to evaluate our ability to generate profitable sales.

Adjusted EBITDA and Adjusted EBITDA Margin contain certain other limitations, including the failure to reflect our cash expenditures, cash requirements for working capital needs, cash expenditures to replace assets being depreciated and amortized and interest expense, or the cash requirements necessary to service interest on principal payments on our indebtedness. In evaluating Adjusted EBITDA and Adjusted EBITDA Margin, you should be aware that in the future we will incur expenses that are the same as or similar to some of the adjustments in this presentation, such as stock-based compensation expense, derivative fair value adjustments, and foreign currency transaction losses. Management compensates for these limitations by relying on our GAAP results and using non-GAAP measures on a supplemental basis.

The following table presents a reconciliation of Adjusted EBITDA to Net income, the most comparable GAAP measure, for each of the periods presented.

(In thousands)

(In thousands)

Three Months Ended December 31, 2020 2019 Nine Months Ended December 31, 2020 2019
Net income (loss) $54,041 $23,659 $205,314 $(195,330)
Depreciation and amortization 35,762 31,172 107,321 74,432
Interest expense 8,433 13,191 27,763 70,787
Income tax expense 20,264 4,032 79,291 22,855
EBITDA 118,500 72,054 419,689 (27,256)
Loss on disposal of assets and costs from exit and disposal activities 980 1,755 3,254 4,466
ESOP and stock-based compensation expense 18,325 11,283 45,413 27,365
ESOP special dividend compensation(a) — — — 246,752
Transaction costs(b) 54 1,814 1,428 22,649
Inventory step up related to the Acquisition — 2,107 — 7,880
Strategic growth and operational improvement initiatives(c) 573 1,735 2,689 4,631
COVID-19 related costs(d) — — 806 —
Other adjustments(e) 431 566 (872) 3,287
Adjusted EBITDA $138,863 $91,314 $472,407 $289,774
Adjusted EBITDA Margin 28.6% 23.2% 30.7% 22.2%

(a) In the first quarter of fiscal 2020, the Company paid a special dividend of $1.00 per share. The dividend was used to pay back a portion of the ESOP loan resulting in $246.8 million in additional stock-based compensation. See “Note 9. Net Income Per Share and Stockholders’ Equity” for additional information.

(b) Represents expenses recorded related to legal, accounting and other professional fees incurred in connection with business or asset acquisitions and dispositions.

(c) Represents professional fees incurred in connection with our strategic growth and operational improvement initiatives, which include various market feasibility assessments and acquisition strategies, along with our operational improvement initiatives, which include evaluation of our manufacturing network and improvement initiatives.

(d) Includes expenses directly related to our response to the COVID-19 pandemic, including adjustments to our pandemic pay program and expenses associated with our third party crisis management vendor.

(e) Includes derivative fair value adjustments, foreign currency transaction (gains) losses, the proportionate share of interest, income taxes, depreciation and amortization related to the South American Joint Venture, which is accounted for under the equity method of accounting and executive retirement expense. The other adjustments in fiscal 2020 also includes expenses related to the ADS Mexicana’s investigation.

The following table presents our Adjusted EBITDA for the Company prior to the Acquisition (“Legacy ADS”), which consists of the combination of the Segment Adjusted Gross Profit for Pipe, Allied Products & Other, and International plus the portion of corporate and selling expenses which impacts Adjusted EBITDA and Infiltrator Water Technologies after the Acquisition (“Legacy Infiltrator Water Technologies”), which consists of the combination of the Segment Adjusted Gross Profit for Infiltrator Water Technologies plus the portion of corporate and selling expenses which impacts Adjusted EBITDA.

(In thousands)

(In thousands)

Legacy ADS Adjusted EBITDA Three Months Ended December 31, 2020 2019 Nine Months Ended December 31, 2020 2019
Pipe Adjusted Gross Profit $78,651 $61,025 $269,746 $192,764
International Adjusted Gross Profit 12,986 9,066 38,976 29,134
Allied Products & Other Adjusted Gross Profit 55,158 42,818 176,006 157,626
Unallocated corporate and selling expenses (48,726) (47,257) (141,819) (139,489)
Legacy ADS Adjusted EBITDA $98,069 $65,652 $342,909 $240,035
Legacy Infiltrator Water Technologies Adjusted EBITDA
Infiltrator Water Technologies Adjusted Gross Profit 48,518 34,735 149,551 64,879
Unallocated corporate and selling expenses (6,994) (8,192) (19,525) (13,281)
Legacy Infiltrator Water Technologies Adjusted EBITDA $41,524 $26,543 $130,026 $51,598
Intersegment eliminations (730) (881) (528) (1,859)
Consolidated Adjusted EBITDA $138,863 $91,314 $472,407 $289,774

Liquidity and Capital Resources

Historically we have funded our operations through internally generated cash flow supplemented by debt financings, equity issuance and finance and operating leases. These sources have been sufficient historically to fund our primary liquidity requirements, including working capital, capital expenditures, debt service and dividend payments for our convertible preferred stock and common stock. From time to time, we may explore additional financing methods and other means to raise capital. There can be no assurance that any additional financing will be available to us on acceptable terms or at all.

The following table presents key liquidity metrics utilized by management. The table includes the Non-GAAP measure, Free Cash Flow, which is further discussed and defined below, and Leverage ratio which is calculated as the trailing twelve months Adjusted EBITDA divided by net debt.

(Amounts in thousands)

Nine Months Ended December 31, 2020 2019
Net cash provided by operating activities $448,776 $296,318
Capital expenditures (57,675) (46,293)
Free Cash Flow 391,101 250,025
Total debt (debt and finance lease obligations) 843,838
Cash 223,996
Net debt (total debt less cash) 619,842
Leverage Ratio 1.1

Free Cash Flow - Free cash flow is a non-GAAP financial measure that comprises cash flow from operations less capital expenditures. Free cash flow is a measure used by management and our Board of Directors to assess our ability to generate cash. Accordingly, free cash flow has been presented in this Quarterly Report on Form 10-Q as a supplemental measure of liquidity that is not required by, or presented in accordance with GAAP, because management believes that free cash flow provides useful information to investors and others in understanding and evaluating our ability to generate cash flow from operations after capital expenditures.

Free cash flow is not a GAAP measure of our liquidity and should not be considered as an alternative to cash flow from operating activities as a measure of liquidity or any other liquidity measure derived in accordance with GAAP. Our measure of free cash flow is not necessarily comparable to other similarly titled captions of other companies due to different methods of calculation.

Net cash provided by operating activities increased $152.5 million to $448.8 million, as compared to $296.3 million in the prior year, primarily due to improvements in profitability and lower cash transaction costs for the Infiltrator Water Technologies acquisition. Free cash flow (Non-GAAP) increased $141.1 million to $391.1 million, as compared to $250.0 million in the prior year. Net debt (total debt and finance lease obligations net of cash) was $619.8 million as of December 31, 2020.

The following table summarizes our available liquidity for the periods presented .

(Amounts in thousands)

December 31, 2020
Revolver capacity $350,000
Less: outstanding borrowings —
Less: letters of credit 11,005
Revolver available liquidity $338,995

In addition to the available liquidity above, we have the ability to borrow up to $1.3 billion under our Term Loan Facility, subject to leverage ratio restrictions.

Working Capital and Cash Flows

As of December 31, 2020, we had $563.0 million in liquidity, including $224.0 million of cash, $339.0 million in borrowings available under our Revolving Credit Agreement, net of $11.0 million of outstanding letters of credit. We believe that our cash on hand, together with the availability of borrowings under our new Credit Agreement and other financing arrangements and cash generated from operations, will be sufficient to meet our working capital requirements, anticipated capital expenditures, scheduled principal and interest payments on our indebtedness and the dividend payment requirement for our convertible preferred stock for at least the next twelve months.

Working Capital - Working capital decreased to $386.0 million as of December 31, 2020, from $428.0 million as of March 31, 2020. The decrease in working capital is primarily due to decreased inventory as a result of increased sales demand and accounts receivable and increased accounts payable and other current liabilities. These decreases were offset by increased cash.

(Amounts in thousands)

Nine Months Ended December 31, 2020 2019
Net cash provided by operating activities $448,776 $296,318
Net cash used in investing activities (57,159) (1,135,862)
Net cash (used in) provided by financing activities (343,116) 928,416

Operating Cash Flows – Cash flows from operating activities during the nine months ended December 31, 2020 was primarily impacted by improved profitability and lower cash transaction costs for the Infiltrator Water Technologies acquisition.

Investing Cash Flows - Capital expenditures during the nine months ended December 31, 2020 increased by $11.4 million compared to the same period in fiscal 2020. The net cash used in investing activities were primarily due to the acquisition of Infiltrator Water Technologies in fiscal 2020.

Capital expenditures totaled $57.7 million and $46.3 million for the nine months ended December 31, 2020 and 2019, respectively. Infiltrator Water Technologies capital expenditures for the nine months ended December 31, 2020 was $40.6 million of our total capital expenditures. Our capital expenditures for the nine months ended December 31, 2020 were used primarily to support facility expansions, equipment replacements, our recycled resin and technology improvement initiatives.

We currently anticipate that we will make capital expenditures of approximately $80 to $90 million in fiscal year 2021. Such capital expenditures are expected to be financed using funds generated by operations. As of December 31, 2020, there were no material contractual obligations or commitments related to these planned capital expenditures.

Financing Cash Flows - During the nine months ended December 31, 2020, cash used in financing activities included the repayment of $205.3 million on the Term Loan Facility, the repayment of $100.0 million on the Revolving Credit Facility, dividend payments of $24.5 million and payments on our finance lease obligations of $15.9 million.

During the nine months ended December 31, 2019, cash provided by financing activities was $928.4 million due to the new Term Loan Facility, Senior Notes and common stock offering. These cash inflows were offset by the repayment of the PNC Credit Agreement and Prudential Senior Notes, the special and quarterly dividend payments of $83.8 million and payments on our finance lease obligations of $18.4 million. The table below summarizes the cash flows from the Acquisition, and the related debt and equity transactions:

(Amounts in thousands)

Sources Uses
Bridge Loan Facility $1,300,000 $—
Bridge Revolver 145,000 —
PNC Credit Agreement draw 104,429 —
Prudential Senior Notes payoff — (104,429)
PNC Credit Agreement payoff — (239,240)
Acquisition of Infiltrator Water Technologies, fair value of consideration transferred — (1,146,526)
Common stock offering, net of offering costs 293,648 —
Bridge Loan Facility - payment — (300,000)
Proceeds from Senior Notes Issuance 350,000 —
Bridge Loan Facility - payment — (300,000)
Term Loan Facility 700,000 —
Bridge Loan Facility - payment — (700,000)
Debt issuance costs — (34,606)
Cash to Balance Sheet — (68,276)
Total $2,893,077 $(2,893,077)

Cash held by Foreign Subsidiaries - As of December 31, 2020, we had $31.5 million in cash that was held by our foreign subsidiaries. We continue to evaluate our strategy regarding foreign cash, but our earnings in foreign subsidiaries still remain indefinitely reinvested.

Employee Stock Ownership Plan (“ESOP”)

The Company established the Advanced Drainage Systems, Inc. ESOP (the “ESOP” or the “Plan”) effective April 1, 1993 to enable eligible employees to acquire stock ownership in ADS in the form of redeemable convertible preferred shares. The Plan was funded by an existing tax-qualified profit-sharing retirement plan, as well as a 30-year term loan from ADS. Within 30 days following the repayment of the ESOP loan, which will occur no later than March 2023, the ESOP committee can direct the shares of redeemable convertible preferred stock owned by the ESOP to be converted into shares of the Company’s common stock.

The Company is obligated to make contributions to the Plan, which, when aggregated with the Plan’s dividends, equal the amount necessary to enable the Plan to make its regularly scheduled payments of principal and interest due on its term loan to ADS. Compensation expense is recognized based upon the average annual fair value of the shares during the period which ADS receives payments on the term loan, and the number of ESOP shares allocated to participant accounts.

As disclosed in “Note 16. Employee Benefit Plans” to the Consolidated Financial Statements included in “Item 8. Financial Statements and Supplementary Data” of our Fiscal 2020 Form 10-K, redeemable convertible preferred stock can convert to common stock upon retirement, disability, death, or vested terminations over the life of the Plan. As stated above, within 30 days following the repayment of the ESOP loan, all redeemable convertible preferred stock will be converted to common stock, which will be no later than March 2023.

The ESOP’s conversion of redeemable convertible preferred stock into common stock will have a meaningful impact on the Company’s net income, net income per share and common shares outstanding. The outstanding shares of common stock would be 24% greater after conversion.

Impact on Net Income - Following the repayment of the ESOP loan discussed above, the Company will no longer be required to apply the two-class method to determine Net income per share. In addition, the Company would not be required to recognize the fair value of ESOP deferred compensation attributable to the shares of redeemable convertible preferred shares allocated.

The impact of the ESOP on net income includes the fair value of ESOP deferred compensation attributable to the shares of redeemable convertible preferred stock allocated to employee ESOP accounts during the applicable period, which is a non-cash charge to our earnings and not deductible for income tax purposes.

(In thousands)

(In thousands)

Three Months Ended December 31, 2020 2019 Nine Months Ended December 31, 2020 2019
Net income (loss) attributable to ADS $53,774 $23,288 $204,476 $(195,479)
ESOP special dividend compensation — — — 246,752
ESOP deferred stock-based compensation 13,513 7,411 29,506 18,481

Impact on Common Stock Outstanding - The repayment of the ESOP loan and related conversion of redeemable convertible preferred shares will have an impact on the number of common shares outstanding. As shares are converted, the number of common shares outstanding will increase.

(Shares in millions)

(Shares in millions)

Three Months Ended December 31, 2020 2019 Nine Months Ended December 31, 2020 2019
Weighted average common shares outstanding 70.5 68.5 69.9 62.1
Conversion of redeemable convertible shares 15.8 17.1 16.2 17.3

Financing Transactions

New Senior Secured Credit Facility - In July 2019, the Company entered into the Base Credit Agreement by and among the Company, as borrower, Barclays Bank PLC, as administrative agent, the several lenders from time to time party thereto. In September 2019, the Company amended the Base Credit Agreement. The Senior Secured Credit Facility provides the Term Loan Facility in an initial aggregate principal amount of $700 million, the Revolving Credit Facility in an initial aggregate principal amount of up to $350 million, the L/C Facility in the initial aggregate available amount of up to $50 million, as a sublimit of such Revolving Credit Facility and a swing line sub-facility in the aggregate available amount of up to $50 million, as a sublimit of the Revolving Credit Facility. As of December 31, 2020, the outstanding principal drawn on Term Loan Facility was $443.0 million and the no outstanding principal on the Revolving Credit Facility. The Company had $339.0 million available to be drawn on the Revolving Credit Facility, net of $11.0 million of outstanding letters of credit.

ADS Mexicana Revolving Credit Facility - The Company and ADS Mexicana entered into an Intercompany Revolving Credit Promissory Note (the “Intercompany Note”) with a capacity of $12.0 million on June 22, 2018. The Intercompany Note matures on June 22, 2022. The Intercompany Note indemnifies the ADS Mexicana joint venture partner for 49% of any unpaid borrowing. The interest rates under the Intercompany Note are determined by certain base rates or LIBOR rates plus an applicable margin based on the Leverage Ratio. As of December 31, 2020 and March 31, 2020, there were no borrowings under the Intercompany Note.

Issuance of Senior Notes due 2027 - On September 23, 2019, the Company issued $350.0 million aggregate principal amount of its Senior Notes, pursuant to the Indenture among the Company, the Guarantors and the Trustee. The Senior Notes are guaranteed by each of the Company’s present and future direct and indirect wholly owned domestic subsidiaries that is a guarantor under the Company's Senior Secured Credit Facility. The Senior Notes were offered and sold either to persons reasonably believed to be “qualified institutional buyers” pursuant to Rule 144A under the Securities Act or to persons outside the United States under Regulation S of the Securities Act.

Interest on the Senior Notes will be payable semi-annually in cash in arrears on March 31 and September 30 of each year, commencing on March 31, 2020, at a rate of 5.000% per annum. The Senior Notes will mature on September 30, 2027. The Company used the majority of the net proceeds from the offering of the Senior Notes for the repayment of $300.0 million of its outstanding borrowings under the Company’s Base Credit Agreement.

The Company may redeem the Senior Notes, in whole or in part, at any time on or after September 30, 2022 at established redemption prices. At any time prior to September 30, 2022, the Company may also redeem up to 40% of the Senior Notes with net cash proceeds of certain equity offerings at a redemption price equal to 105.000% of the principal amount of the Senior Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. In addition, at any time prior to September 30, 2022, the Company may redeem the Senior Notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the Senior Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date plus an applicable “make-whole” premium.

The Indenture contains customary events of default, including, among other things, payment default, failure to comply with covenants or agreements contained in the Indenture or the Senior Notes and certain provisions related to bankruptcy events. The Indenture also contains customary negative covenants.

Covenant Compliance - The Senior Secured Credit Facility requires, if the aggregate amount of outstanding exposure under the Revolving Facility exceeds $122.5 million at the end of any fiscal quarter, the Company maintain a consolidated senior secured net leverage ratio (commencing with the fiscal quarter ending March 31, 2020) not to exceed 4.25 to 1.00 for any four consecutive fiscal quarter periods.

The Senior Secured Credit Facility also includes other covenants, including negative covenants that, subject to certain exceptions, limit the Company’s and its restricted subsidiaries’ (as defined in the Credit Agreement) ability to, among other things: (i) incur additional debt, including guarantees; (ii) create liens upon any of their property; (iii) enter into any merger, consolidation or amalgamation, liquidate, wind up or dissolve, or dispose of all or substantially all of their property or business; (iv) dispose of assets; (v) pay subordinated debt; (vi) make certain investments; (vii) enter into swap agreements; (viii) engage in transactions with affiliates; (ix) engage in new lines of business; (x) modify certain material contractual obligations, organizational documents, accounting policies or fiscal year; or (xi) create or permit restrictions on the ability of any subsidiary of any Loan Party (as defined in the Senior Secured Credit Facility) to pay dividends or make distributions to the Company or any of its subsidiaries.

The Senior Secured Credit Facility also contains customary provisions requiring the following mandatory prepayments (subject to certain exceptions and limitations): (i) annual prepayments (beginning with the fiscal year ending March 31, 2021) with a percentage of excess cash flow (as defined in the Senior Secured Credit Facility); (ii) 100% of the net cash proceeds from any non-ordinary course sale of assets and certain casualty or condemnation events; and (iii) 100% of the net cash proceeds of indebtedness not permitted to be incurred under the Senior Secured Credit Facility.

For further information, see “Note 11. Debt” to the Consolidated Financial Statements in our Fiscal 2020 Form 10-K. We are in compliance with our debt covenants as of December 31, 2020.

Off-Balance Sheet Arrangements

Excluding the guarantees of 50% of certain debt of our unconsolidated South American Joint Venture as further discussed in “Note 10. Related Party Transactions” to the Condensed Consolidated Financial Statements, we do not have any other off-balance sheet arrangements. As of December 31, 2020, our South American Joint Venture had approximately $10.1 million of outstanding debt subject to our guarantees. We do not believe that this guarantee will have a current or future effect on our financial condition, results of operations, liquidity, or capital resources.

Critical Accounting Policies and Estimates

There have been no changes in critical accounting policies from those disclosed in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Fiscal 2020 Form 10-K, except as disclosed in Note 1. Background and Summary of Significant Accounting Policies.

Forward-Looking Statements

This Quarterly Report on Form 10-Q (“Form 10-Q”) includes forward-looking statements. Some of the forward-looking statements can be identified by the use of terms such as “believes,” “expects,” “may,” “will,” “would,” “should,” “could,” “seeks,” “predict,” “potential,” “continue,” “intends,” “plans,” “projects,” “estimates,” “anticipates” or other comparable terms. These forward-looking statements include all matters that are not related to present facts or current conditions or that are not historical facts. They appear in a number of places throughout this Form 10-Q and include statements regarding our intentions, beliefs or current expectations concerning, among other things, our consolidated results of operations, financial condition, liquidity, prospects, growth strategies, and the industries in which we operate and include, without limitation, statements relating to our future performance.

Forward-looking statements are subject to known and unknown risks and uncertainties, many of which are beyond our control. We caution you that forward-looking statements are not guarantees of future performance and that our actual consolidated results of operations, financial condition, liquidity and industry development may differ materially from those made in or suggested by the forward-looking statements contained in this Quarterly Report on Form 10-Q. In addition, even if our actual consolidated results of operations, financial condition, liquidity and industry development are consistent with the forward-looking statements contained in this Form 10-Q, those results or developments may not be indicative of results or developments in subsequent periods. A number of important factors could cause actual results to differ materially from those contained in or implied by the forward-looking statements, including those reflected in forward-looking statements relating to our operations and business, the risks and uncertainties discussed in this Form 10-Q (including under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations”), and those described from time to time in our other filings with the SEC. Factors that could cause actual results to differ from those reflected in forward-looking statements relating to our operations and business include:

  • fluctuations in the price and availability of resins and other raw materials and our ability to pass any increased costs of raw materials on to our customers in a timely manner;
  • volatility in general business and economic conditions in the markets in which we operate, including the adverse impact on the U.S. and global economy of the COVID-19 global pandemic, and the impact of COVID-19 in the near, medium and long-term on our business, results of operations, financial position, liquidity or cash flows, and other factors relating to availability of credit, interest rates, fluctuations in capital and business and consumer confidence;
  • cyclicality and seasonality of the non-residential and residential construction markets and infrastructure spending;
  • the risks of increasing competition in our existing and future markets, including competition from both manufacturers of high performance thermoplastic corrugated pipe and manufacturers of products using alternative materials;
  • uncertainties surrounding the integration of acquisitions and similar transactions, including the acquisition and integration of Infiltrator Water Technologies;
  • our ability to realize the anticipated benefits from the acquisition of Infiltrator Water Technologies;
  • risks that the acquisition of Infiltrator Water Technologies and related transactions may involve unexpected costs, liabilities or delays;
  • our ability to continue to convert current demand for concrete, steel and polyvinyl chloride (“PVC”) pipe products into demand for our high performance thermoplastic corrugated pipe and Allied Products;
  • the effect of any claims, litigation, investigations or proceedings, including those described below under “Part II. Other Information Item 1. Legal Proceedings” of this Quarterly Report;
  • the effect of weather or seasonality;
  • the loss of any of our significant customers;
  • the risks of doing business internationally;
  • our ability to remediate the material weakness in our internal control over financial reporting, including remediation of the control environment for our joint venture affiliate ADS Mexicana, S.A. de C.V. as described in “Item 9A. Controls and Procedures” of our Fiscal 2020 Form 10-K;
  • the risks of conducting a portion of our operations through joint ventures;
  • our ability to expand into new geographic or product markets, including risks associated with new markets and products associated with our recent acquisition of Infiltrator Water Technologies; our ability to achieve the acquisition component of our growth strategy;
  • the risk associated with manufacturing processes;
  • our ability to manage our assets;
  • the risks associated with our product warranties;
  • our ability to manage our supply purchasing and customer credit policies;
  • the risks associated with our self-insured programs;
  • our ability to control labor costs and to attract, train and retain highly qualified employees and key personnel;
  • our ability to protect our intellectual property rights;
  • changes in laws and regulations, including environmental laws and regulations;
  • our ability to project product mix;
  • the risks associated with our current levels of indebtedness, including borrowings under our new Credit Agreement and outstanding indebtedness under our Senior Notes;
  • the nature, cost and outcome of any future litigation and other legal proceedings, including any such proceedings related to our acquisition of Infiltrator Water Technologies as may be instituted against the Company and others;
  • fluctuations in our effective tax rate, including from the Tax Cuts and Jobs Act of 2017;
  • our ability to meet future capital requirements and fund our liquidity needs;
  • the risk that information may arise that would require the Company to make adjustments or revisions or to restate further the financial statements and other financial data for certain prior periods and any future periods;
  • any delay in the filing of any filings with the SEC;
  • the review of potential weaknesses or deficiencies in the Company’s disclosure controls and procedures, and discovering further weaknesses of which we are not currently aware or which have not been detected; and
  • additional uncertainties related to accounting issues generally.

All forward-looking statements are made only as of the date of this report and we do not undertake any obligation, other than as may be required by law, to update or revise any forward-looking statements to reflect future events or developments. Comparisons of results for current and any prior periods are not intended to express any future trends, or indications of future performance, unless expressed as such, and should only be viewed as historical data.

Market risk

As filed, 1,829 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We are subject to various market risks, primarily related to changes in interest rates, credit, raw material supply prices and, to a lesser extent, foreign currency exchange rates. Our financial position, results of operations or cash flows may be negatively impacted in the event of adverse movements in the respective market rates or prices in each of these risk categories. Our exposure in each category is limited to those risks that arise in the normal course of business, as we do not engage in speculative, non-operating transactions. Our exposure to market risk has not materially changed from what we previously disclosed in Part II. Item 7A. “Quantitative and Qualitative Disclosures about Market Risk” of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020, except as disclosed below.

Interest Rate Risk - We are subject to interest rate risk associated with our bank debt. Changes in interest rates impact the fair value of our fixed-rate debt, but there is no impact to earnings and cash flow. Alternatively, changes in interest rates do not affect the fair value of our variable-rate debt, but they do affect future earnings and cash flow. The Revolving Credit Facility and the Term Note, notes bear variable interest rates. The Revolving Credit Facility and Term Note bear interest either at LIBOR or the Prime Rate, at our option, plus applicable pricing margins. A 1.0% increase in interest rates on our variable-rate debt would increase our annual forecasted interest expense by approximately $6.0 million based on our borrowings as of December 31, 2020. Assuming the Revolving Credit Facility is fully drawn, each 1.0% increase or decrease in the applicable interest rate would change our interest expense by approximately $9.5 million, for the twelve months ended December 31, 2020.

Controls and procedures

As filed, 2,222 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

The Company’s Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”) are responsible for evaluating the effectiveness of our disclosure controls and procedures as defined in the Securities Exchange Act of 1934, as amended (the “Exchange Act”), rules 13a-15(e) and 15d-15(e). The Company’s disclosure controls and procedures are designed to provide reasonable assurance that the information required to be disclosed in the Company’s reports under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the Company’s CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

As previously disclosed in our Fiscal 2020 Form 10-K, we concluded that our internal control over financial reporting was not effective based upon the material weakness identified as of March 31, 2020. See “Item 9A - Controls and Procedures” in our Fiscal 2019 Form 10-K. Our CEO and CFO have concluded that the material weakness previously identified in the Fiscal 2019 Form 10-K was still present as of December 31, 2020 (the “Evaluation Date”). Based on the material weakness, and the evaluation of our disclosure controls and procedures, our CEO and CFO concluded that the Company’s disclosure controls and procedures were not effective as of the Evaluation Date.

Changes in Internal Control over Financial Reporting

There were no changes in the Company’s internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act that occurred during the three months ended December 31, 2020 that has materially affected, or is reasonably likely to materially affect, internal control over financial reporting.

Risk factors

As filed, 573 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Important risk factors that could affect our operations and financial performance, or that could cause results or events to differ from current expectations, are described in “Part I, Item 1A — Risk Factors” of our Fiscal 2020 Form 10-K. These factors are further supplemented by those discussed in “Part II, Item 7A — Quantitative and Qualitative Disclosures about Market Risk” of our Fiscal 2020 Form 10-K and in “Part I, Item 3 — Quantitative and Qualitative Disclosures about Market Risk” and “Part II, Item 1 — Legal Proceedings” of this Quarterly Report on Form 10-Q.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-10-01 to 2020-12-31$486.1mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2020-04-01 to 2020-12-31$1.54bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Gross profit3 months2020-10-01 to 2020-12-31$168.5mus-gaap:GrossProfit
Gross profit9 months2020-04-01 to 2020-12-31$562.9mus-gaap:GrossProfit
Operating income3 months2020-10-01 to 2020-12-31$83.0mus-gaap:OperatingIncomeLoss
Operating income9 months2020-04-01 to 2020-12-31$311.6mus-gaap:OperatingIncomeLoss
Income tax3 months2020-10-01 to 2020-12-31$20.3mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2020-04-01 to 2020-12-31$79.3mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-10-01 to 2020-12-31$53.8mus-gaap:NetIncomeLoss
Net income9 months2020-04-01 to 2020-12-31$204.5mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-10-01 to 2020-12-31$0.62us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2020-04-01 to 2020-12-31$2.38us-gaap:EarningsPerShareDiluted
Basic EPS3 months2020-10-01 to 2020-12-31$0.63us-gaap:EarningsPerShareBasic
Basic EPS9 months2020-04-01 to 2020-12-31$2.42us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2020-10-01 to 2020-12-3171,586,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2020-04-01 to 2020-12-3170,853,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2020-04-01 to 2020-12-31$448.8mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2020-10-01 to 2020-12-31$28.7mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Capital expenditure9 months2020-04-01 to 2020-12-31$57.7mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2020-12-31$224.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-12-31$663.5mus-gaap:AssetsCurrent
Total assetsAt period end2020-12-31$2.34bnus-gaap:Assets
Current liabilitiesAt period end2020-12-31$277.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-12-31$1.32bnus-gaap:Liabilities
Long-term debtAt period end2020-12-31$783.9mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2020-12-31$7.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2020-12-31$772.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-21-004304. Last ingested by Listed: Nov 14, 2026, 20:53 ET. Listed shows no prices and gives no investment advice.